EarlySense Monitoring Device Evaluation on CHF Patients

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00382746

Enrollment

Registered

2006-09-29

Start date

2006-10-31

Completion date

2008-03-31

Last updated

2016-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congestive Heart Failure

Keywords

Congestive, Heart, Failure, CHF

Brief summary

CHF patients will be monitored using EarlySense ES-16 device and will simultaneously fill diaries and log their weight daily. The data collected and analyzed by the ES-16 device will be correlated with the CHF status data.

Interventions

DEVICEEarlySense monitoring device

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

45 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age over 45 years old * CHF class II or III with LVEF\<40% * Hospitalized at least once for CHF deterioration over previous 12 month period * Able and willing to cooperate with this trial for at least a 3 month period * Home close to participating center

Exclusion criteria

* Recent (within 3 month) admission to ICU or CC-ICU due to severe CHF episode requiring artificial ventilation * Asthma or COPD

Design outcomes

Primary

Measure	Time frame
CHF	1 month

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026